Literature DB >> 16362222

Bioceramics composition modulate resorption of human osteoclasts.

Y Ramaswamy1, D R Haynes, G Berger, R Gildenhaar, H Lucas, C Holding, H Zreiqat.   

Abstract

Biomaterials used in bone regeneration are designed to be gradually resorbed by the osteoclast and replaced by new bone formed through osteoblastic activity. The aim of the present study is to analyze the role of osteoclasts in the resorption process. The attachment of human osteoclasts and the appearance of their resorption lacunae, when cultured on either the resorbable crystalline, calcium orthophosphate materials or on the long-term stable bioceramic material was investigated. The resorbable materials contain Ca10[K,Na](PO4)7 (AW-Si) and Ca2KNa(PO4)2 (GB14, GB9 & D9/25) as their main crystal phases, however they differ in their total solubility. These differences result from small variations in the composition. The long-term stable material consist of about 30% fluorapatite beside calcium zirconium phosphate (Ca5(PO4)3F + CaZr4(PO4)6) and shows a very small solubility. AW-Si has an alkali containing crystalline phase, Ca10[K,Na](PO4). While GB14, GB9 and D9/25 contain the crystalline phase Ca2KNa(PO4)2 with small additions of crystalline and amorphous diphosphates and/or magnesium potassium phosphate (GB14). D9/25 and AW-Si is less soluble compared to GB14, and GB9 among the resorbable materials. Resorbable and long-term stable materials vary in their chemical compositions, solubility, and surface morphology. Osteoclasts modified the surface in their attempts to resorb the materials irrespective of the differences in their physical and chemical properties. The depth and morphology of the resorption imprints were different depending on the type of material. These changes in the surface structure created by osteoclasts are likely to affect the way osteoblasts interact with the materials and how bone is subsequently formed.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16362222     DOI: 10.1007/s10856-005-4729-0

Source DB:  PubMed          Journal:  J Mater Sci Mater Med        ISSN: 0957-4530            Impact factor:   3.896


  38 in total

Review 1.  Intracellular membrane trafficking in bone resorbing osteoclasts.

Authors:  Mika Mulari; Jukka Vääräniemi; H Kalervo Väänänen
Journal:  Microsc Res Tech       Date:  2003-08-15       Impact factor: 2.769

Review 2.  Integrin-mediated signaling in the regulation of osteoclast adhesion and activation.

Authors:  L T Duong; G A Rodan
Journal:  Front Biosci       Date:  1998-08-01

3.  Osteoclastic resorption of calcium phosphate ceramics with different hydroxyapatite/beta-tricalcium phosphate ratios.

Authors:  S Yamada; D Heymann; J M Bouler; G Daculsi
Journal:  Biomaterials       Date:  1997-08       Impact factor: 12.479

4.  Response of human osteoblasts to implant materials: integrin-mediated adhesion.

Authors:  G Gronowicz; M B McCarthy
Journal:  J Orthop Res       Date:  1996-11       Impact factor: 3.494

Review 5.  Bone resorption by osteoclasts.

Authors:  S L Teitelbaum
Journal:  Science       Date:  2000-09-01       Impact factor: 47.728

6.  Radio-opaque agents in bone cement increase bone resorption.

Authors:  A Sabokbar; Y Fujikawa; D W Murray; N A Athanasou
Journal:  J Bone Joint Surg Br       Date:  1997-01

7.  Mechanisms of magnesium-stimulated adhesion of osteoblastic cells to commonly used orthopaedic implants.

Authors:  H Zreiqat; C R Howlett; A Zannettino; P Evans; G Schulze-Tanzil; C Knabe; M Shakibaei
Journal:  J Biomed Mater Res       Date:  2002-11

8.  In vitro studies of human and rat osteoclast activity on hydroxyapatite, beta-tricalcium phosphate, calcium carbonate.

Authors:  F Monchau; A Lefèvre; M Descamps; A Belquin-myrdycz; P Laffargue; H F Hildebrand
Journal:  Biomol Eng       Date:  2002-08

9.  The modulation of osteogenesis in vitro by calcium titanium phosphate coatings.

Authors:  C Knabe; G Berger; R Gildenhaar; F Klar; H Zreiqat
Journal:  Biomaterials       Date:  2004-09       Impact factor: 12.479

10.  In vitro investigation of novel calcium phosphates using osteogenic cultures.

Authors:  C Knabe; W Ostapowicz; R J Radlanski; R Gildenhaar; G Berger; R Fitzner; U Gross
Journal:  J Mater Sci Mater Med       Date:  1998-06       Impact factor: 3.896

View more
  7 in total

1.  In vivo behaviour of low-temperature calcium-deficient hydroxyapatite: comparison with deproteinised bovine bone.

Authors:  Pavel Sponer; Marie Strnadová; Karel Urban
Journal:  Int Orthop       Date:  2010-08-19       Impact factor: 3.075

2.  Self-assembling peptide nanofibers coupled with neuropeptide substance P for bone tissue engineering.

Authors:  Su Hee Kim; Woojune Hur; Ji Eun Kim; Hye Jeong Min; Sukwha Kim; Hye Sook Min; Byeung Kyu Kim; Soo Hyun Kim; Tae Hyun Choi; Youngmee Jung
Journal:  Tissue Eng Part A       Date:  2015-01-13       Impact factor: 3.845

3.  Titanium-enriched hydroxyapatite-gelatin scaffolds with osteogenically differentiated progenitor cell aggregates for calvaria bone regeneration.

Authors:  João R Ferreira; Ricardo Padilla; Ganokon Urkasemsin; Kun Yoon; Kelly Goeckner; Wei-Shou Hu; Ching-Chang Ko
Journal:  Tissue Eng Part A       Date:  2013-04-16       Impact factor: 3.845

4.  Engipore acts on human bone marrow stem cells.

Authors:  Vincenzo Sollazzo; Annalisa Palmieri; Ambra Girardi; Francesca Farinella; Francesco Carinci
Journal:  Saudi Dent J       Date:  2010-07-17

5.  Surface-induced regulation of podosome organization and dynamics in cultured osteoclasts.

Authors:  Dafna Geblinger; Benjamin Geiger; Lia Addadi
Journal:  Chembiochem       Date:  2009-01-05       Impact factor: 3.164

6.  Osteoplant acts on stem cells derived from peripheral blood.

Authors:  Vincenzo Sollazzo; Annalisa Palmieri; Ambra Girardi; Ilaria Zollino; Giorgio Brunelli; Giuseppe Spinelli; Francesco Carinci
Journal:  J Indian Soc Periodontol       Date:  2010-01

7.  Histologic and Histomorphometric Analysis of Bone Regeneration with Bovine Grafting Material after 24 Months of Healing. A Case Report.

Authors:  Renzo Guarnieri; Fabrizio Belleggia; Patricia DeVillier; Luca Testarelli
Journal:  J Funct Biomater       Date:  2018-08-08
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.